BackSelecta Biosciences Overview

Selecta Biosciences Net Tangible Assets

Track Selecta Biosciences's net tangible assets ($-150M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$-148.12M

Peer average

Loading

Selecta Biosciences Net Tangible Assets History

Loading

Selecta Biosciences vs. peers: Net Tangible Assets Comparison

Loading

Selecta Biosciences Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Selecta Biosciences (SELB) FAQ

Selecta Biosciences (SELB) currently reports a net tangible assets of $-150M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Selecta Biosciences's net tangible assets history and peer comparisons.

Selecta Biosciences's net tangible assets changed from $0 to $-150M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Selecta Biosciences reported $-150M in net tangible assets as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $-150M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Selecta Biosciences, and consider following SELB for alerts when major investors trade the stock.

Selecta Biosciences is classified in the Healthcare sector. On net tangible assets, it currently shows $-150M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SELB with unrelated industries.